Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
R., Stamenkovic, M
Anticipated Costs Post-Approval While neither compound has reached market, pricing for similar medications provides context: Semaglutide (Wegovy) Approximately $1,300-$1,500 monthly without insurance Tirzepatide (Zepbound) Approximately $1,000-$1,200 monthly without insurance Cagrilintide and retatrutide would likely fall in similar price ranges, with combination therapy potentially costing $2,000-$3,000 monthly without insurance coverage
6k) might be associated with the observed ETC insensitivity to FCCP treatment (Fig
Some compounded products also appear in oral troches or capsules, though injection remains the preferred route due to higher bioavailability
